Context Anti-müllerian hormone (AMH) is produced by granulosa cells of small, growing
follicles in the ovary. Serum AMH levels strongly correlate with the number of growing …

This monograph, written by the pioneers of IVF and reproductive medicine, celebrates the
history, achievements, and medical advancements made over the last 40 years in this …

STUDY QUESTION What is the recommended management of ovarian stimulation, based
on the best available evidence in the literature? SUMMARY ANSWER The guideline …

BACKGROUND In women, anti-Müllerian hormone (AMH) is exclusively produced by
granulosa cells of ovarian follicles during the early stages of follicle development. After an …

Ovarian reserve is defined as the number of oocytes remaining in the ovary, or oocyte
quantity (oocyte number). Markers of ovarian reserve include hormone levels and …

BACKGROUND Stratified (individualized) medicine has been recognized as a key priority
for policy makers and healthcare providers. The main principle of individualized care …

Background During a cycle of in vitro fertilisation plus intracytoplasmic sperm injection
(IVF/ICSI), women receive daily doses of gonadotropin follicle‐stimulating hormone (FSH) to …

STUDY DESIGN, SIZE, DURATION: The guideline was developed according to the
structured methodology for development of ESHRE guidelines. After formulation of key …

Ovarian hyperstimulation syndrome (OHSS) is a potentially life-threating iatrogenic
complication of the early luteal phase and/or early pregnancy after in vitro fertilization (IVF) …

Objective To identify, appraise and summarize the current evidence regarding the
pathophysiology, staging, prediction and prevention of ovarian hyperstimulation syndrome …